Survival benefit of hyperthermia in a prospective randomized trial of brachytherapy boost ± hyperthermia for glioblastoma multiforme

Agbi, 1992, Patterns of recurrence of malignant astrocytoma following stereotactic interstitial brachytherapy with iodine-125 implants, Int. J. Radiat. Oncol. Biol. Phys., 23, 321, 10.1016/0360-3016(92)90748-7 Cox, 1972, Regression models and life tables, J. R. Stat. Soc., 34, 187 Dewey, 1980, Cell biology of hyperthermia and radiation, 589 Dewhirst, 1990, RTOG quality assurance guidelines for clinical trials using hyperthermia, Int. J. Radiat. Oncol. Biol. Phys., 18, 1249, 10.1016/0360-3016(90)90466-W Emami, 1996, Phase III study of interstitial thermoradiotherapy compared with interstitial radiotherapy alone in the treatment of recurrent or persistent human tumors: a prospectively controlled randomized study by the Radiation Therapy Oncology Group, Int. J. Radiat. Oncol. Biol. Phys., 34, 1097, 10.1016/0360-3016(95)02137-X Emami, 1991, RTOG quality assurance guidelines for interstitial hyperthermia, Int. J. Radiat. Oncol. Biol. Phys., 20, 1117, 10.1016/0360-3016(91)90213-N Gaspar, 1992, Hyperthermia and brachytherapy for glioma—will cooler heads prevail?, Int. J. Radiat. Oncol. Biol. Phys., 24, 803, 10.1016/0360-3016(92)90732-W Kaplan, 1958, Nonparametric estimation from incomplete observations, J. Am. Stat. Assoc., 53, 457, 10.1080/01621459.1958.10501452 Kapp, 1995, Thermal treatment parameters are most predictive of outcome in patients with single tumor nodules per treatment field in recurrent adenocarcinoma of the breast, Int. J. Radiat. Oncol. Biol. Phys., 33, 887, 10.1016/0360-3016(95)00212-4 Leopold, 1993, Cumulative minutes with T90 greater than Tempindex is predictive of response of superficial malignancies to hyperthermia and radiation, Int. J. Radiat. Oncol. Biol. Phys., 25, 841, 10.1016/0360-3016(93)90314-L Mantel, 1966, Evaluation of survival data and two new rank order statistics arising in its consideration, Cancer Chemother. Rep., 50, 163 McDermott, 1990, Interstitial brachytherapy, Neurosurg. Clin. North Am., 1, 801, 10.1016/S1042-3680(18)30774-5 Oleson, 1995, Hyperthermia from the clinic to the laboratory: a hypothesis, Int. J. Hyperthermia, 11, 315, 10.3109/02656739509022467 Oleson, 1993, Sensitivity of hyperthermia trial outcomes to temperature and time: implications for thermal goals of treatment, Int. J. Radiat. Oncol. Biol. Phys., 25, 289, 10.1016/0360-3016(93)90351-U Overgaard, 1990, The current and potential role of hyperthermia in radiotherapy, Int. J. Radiat. Oncol. Biol. Phys., 16, 535, 10.1016/0360-3016(89)90470-7 Overgaard, 1996, Hyperthermia as an adjuvant to radiation therapy of recurrent or metastatic melanoma. A multicentre randomised trial by the European Society for Hyperthermic Oncology, Int. J. Hyperthermia, 12, 3, 10.3109/02656739609023685 Perez, 1989, Quality assurance problems in clinical hyperthermia and their impact on therapeutic outcome: a report by the Radiation Therapy Oncology Group, Int. J. Radiat. Oncol. Biol. Phys., 16, 551, 10.1016/0360-3016(89)90471-9 Ryan, 1994, Brain hyperthermia: I. Interstitial microwave antenna array techniques—the Dartmouth experience, Int. J. Radiat. Oncol. Biol. Phys., 29, 1065, 10.1016/0360-3016(94)90402-2 Sapareto, 1984, Thermal dose determination in cancer therapy, Int. J. Radiat. Oncol. Biol. Phys., 10, 787, 10.1016/0360-3016(84)90379-1 Satoh, 1988, Thermal distribution studies of helical coil microwave antennas for interstitial hyperthermia, Int. J. Radiat. Oncol. Biol. Phys., 15, 1209, 10.1016/0360-3016(88)90206-4 Scharfen, 1992, High activity iodine-125 interstitial implant for gliomas, Int. J. Radiat. Oncol. Biol. Phys., 24, 583, 10.1016/0360-3016(92)90702-J Seegenschmiedt, 1995, Thermoradiotherapy for malignant brain tumors: review of biological and clinical studies, Endocurie. Hyperthermia Oncol., 11, 201 Selker, 1995, A randomized trial of interstitial radiotherapy (IRT) boost for the treatment of newly diagnosed malignant glioma (glioblastoma multiforme, anaplastic astrocytoma, anaplastic oligodendroglioma, malignant mixed glioma): BTCG study 87-01 (Abstr.), 94 Sminia, 1994, Effect of hyperthermia on the central nervous system: a review, Int. J. Hyperthermia, 10, 1, 10.3109/02656739409009328 Sneed, 1994, Patterns of recurrence of glioblastoma multiforme after external irradiation followed by implant boost, Int. J. Radiat. Oncol. Biol. Phys., 29, 719, 10.1016/0360-3016(94)90559-2 Sneed, 1992, Thermoradiotherapy of recurrent malignant brain tumors, Int. J. Radiat. Oncol. Biol. Phys., 23, 853, 10.1016/0360-3016(92)90659-6 Sneed, 1996, Demonstration of brachytherapy boost dose-response relationships in glioblastoma multiforme, Int. J. Radiat. Oncol. Biol. Phys., 35, 37, 10.1016/S0360-3016(96)85009-7 Sneed, 1994, Brachytherapy and hyperthermia for malignant astrocytoma, Semin. Oncol., 21, 186 Sneed, 1991, Combining hyperthermia and radiation: how beneficial?, Oncology, 5, 99 Sneed, 1995, Large effect of age on survival of patients with glioblastoma treated with radiotherapy and brachytherapy boost, Neurosurgery, 36, 898, 10.1227/00006123-199505000-00002 Stea, 1992, Treatment of malignant gliomas with interstitial irradiation and hyperthermia, Int. J. Radiat. Oncol. Biol. Phys., 24, 657, 10.1016/0360-3016(92)90711-P Stea, 1994, Interstitial irradiation versus interstitial thermoradiotherapy for supratentorial malignant gliomas: a comparative survival analysis, Int. J. Radiat. Oncol. Biol. Phys., 30, 591, 10.1016/0360-3016(92)90945-E Vernon, 1996, Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials, Int. J. Radiat. Oncol. Biol. Phys., 35, 731, 10.1016/0360-3016(96)00154-X Weaver, 1990, A CT-based computerized treatment planning system for I-125 stereotactic brain implants, Int. J. Radiat. Oncol. Biol. Phys., 18, 445, 10.1016/0360-3016(90)90114-Y Wen, 1994, Long term results of sterotactic brachytherapy used in the initial treatment of patients with glioblastomas, Cancer, 73, 3029, 10.1002/1097-0142(19940615)73:12<3029::AID-CNCR2820731222>3.0.CO;2-4